In vitro-stimulated NKG2C+ NK cells exhibit high cytotoxicity efficiency against HLA-C-mismatched primary ALL, AML, and myelodysplastic syndrome (MDS) blasts ex vivo40–42, demonstrating the strong alloreactivity of NKG2C+ NK cells. The gene discussed is KLRC2; the disease is myelodysplastic syndrome.